Hot Investor Mandate: Pharmaceutical Arm of Japanese Company Seeks First-In-Class Assets in High Unmet Need Indication Areas

12 Dec

A pharmaceutical arm of a large Japanese company with a full-fledged licensing and clinical development office in the USA, is seeking to form partnerships and in-licensing relationships regarding early stage assets in its key indication areas. These partnerships are highly flexible, and may involve the pharma company contributing personnel, sharing studies and research tools, or providing research expense funding.

The firm is interested in early-stage, first-in-class, orally active small molecule NCEs. The firm seeks assets in the following key areas: Metabolic / Cardiovascular Diseases (NASH, Heart failure (HFrEF, HFpEF, Hypertrophic cardiomyopathy), Diabetic Retinopathy / Diabetic Macular Edema, Chronic Kidney Disease, Sarcopenia), Autoimmune Diseases (Multiple Sclerosis, Lupus, IBD), CNS disorders (Alzheimer’s Disease, Schizophrenia). As well as drugs, The firm is interested in drug targets in these disease areas.

The firm is open to forming partnerships regarding very early stage assets, at or prior to the lead optimization phase. For in-licensing for the Japan market, the firm is focused on renal diseases, dermatology and allergic diseases. The firm also invests in drug discovery technologies and research tools such as: technologies related to translational research using cell culture, isolated cellular organelles and related mechanisms; HTS technologies; protein structure analysis; chemical biology, chemical synthesis, and chemical libraries; biophysical tools; in silico technologies; biomarkers and bioinformatics screening, biomarker research, and compound libraries.

If you are interested in more information about this investor and other investors tracked by LSN, please email


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: